Search results for "hypoglycemic"

showing 10 items of 215 documents

Liraglutide Reduces Oxidative Stress And Restores Heme Oxygenase-1 and Ghrelin Levels in Patients with Type 2 Diabetes: A Prospective Pilot Study

2014

Abstract Context: Liraglutide is a glucagon-like peptide-1 analog and glucose-lowering agent whose effects on cardiovascular risk markers have not been fully elucidated. Objective: We evaluated the effect of liraglutide on markers of oxidative stress, heme oxygenase-1 (HO-1), and plasma ghrelin levels in patients with type-2 diabetes mellitus (T2DM). Design and Setting: A prospective pilot study of 2 months' duration has been performed at the Unit of Diabetes and Cardiovascular Prevention at University of Palermo, Italy. Patients and Intervention(s): Twenty subjects with T2DM (10 men and 10 women; mean age: 57 ± 13 y) were treated with liraglutide sc (0.6 mg/d for 2 wk, followed by 1.2 mg/d…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismClinical Biochemistry030209 endocrinology & metabolismContext (language use)Pilot ProjectsType 2 diabetes030204 cardiovascular system & hematologymedicine.disease_causeBiochemistry03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEndocrinologyGlucagon-Like Peptide 1Internal medicineDiabetes mellitusMedicineHumansHypoglycemic AgentsProspective StudiesAgedbusiness.industryLiraglutideBiochemistry (medical)Liraglutide Heme oxygenase Lipid peroxidation Ghrelin Type-2 diabetesOriginal ArticlesLiraglutideMiddle Agedmedicine.diseaseGhrelinMetformin3. Good healthMetforminOxidative StressEndocrinologychemistryDiabetes Mellitus Type 2GhrelinDrug Therapy CombinationFemaleGlycated hemoglobinbusinessOxidative stressHeme Oxygenase-1medicine.drug
researchProduct

Prevalence of psychiatric disorders in an onset cohort of adults with type 1 diabetes

2003

Previous studies indicate a high prevalence of psychiatric disorders in adults with type 1 diabetes mellitus. The aim of our study was to determine if newly diagnosed adults with type 1 diabetes already have an elevated rate of psychiatric disorders at the beginning of their physical illness.The authors consecutively recruited 313 newly diagnosed, adult inpatients with type 1 diabetes (age 17-40 years) from 12 hospitals. A national, representative population sample of 2046 persons of a similar age range served as the reference group. Psychiatric disorders were measured in both groups using structured interviews that provided diagnoses according to DSM-IV.There was a point prevalence of 12.5…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismEndocrinologyReference ValuesGermanyImmunopathologyDiabetes mellitusEpidemiologyPrevalenceInternal MedicinemedicineHumansHypoglycemic AgentsInsulinOccupationsPsychiatryInpatientsType 1 diabetesMarital Statusbusiness.industrymedicine.diseaseComorbidityDiabetes Mellitus Type 1Psychotic DisordersStructured interviewCohortEducational StatusMarital statusFemalebusinessDiabetes/Metabolism Research and Reviews
researchProduct

OCT is not useful for detection of minimal diabetic retinopathy in type 1 diabetes.

2009

Optical coherence tomography (OCT) has been proven useful in measuring retinal thickness (RT) in patients with diabetes, although with discordant results in different studies. We examined RT in patients with type 1 diabetes (T1D) with or without minimal diabetic retinopathy (MDR) to test whether OCT is able to identify early retinal changes and potential correlations with metabolic parameters. RT of 102 patients with T1D (53 females, 49 males, aged 27.03 +/- 7.4 years) and of 42 healthy controls was examined, with analysis of nine different sectors (fovea, four pericentral and four peripheral sectors). According to the results of basal fundus photography, patients were divided into two grou…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and MetabolismGastroenterologyRetinaSettore MED/13 - EndocrinologiaYoung AdultEndocrinologyOptical coherence tomography (OCT) type 1 diabetes (T1D) minimal diabetic retinopathy (MDR)retinal thickness (RT)Predictive Value of TestsInternal medicineDiabetes mellitusInternal MedicinemedicineHumansHypoglycemic AgentsInsulinMacular edemaType 1 diabetesDiabetic Retinopathymedicine.diagnostic_testbusiness.industrySettore MED/30 - Malattie Apparato VisivoFundus photographyGeneral MedicineDiabetic retinopathymedicine.diseaseRadiographyEndocrinologyDiabetes Mellitus Type 1Predictive value of testsMicroalbuminuriaFemalebusinessMedical FutilityTomography Optical CoherenceRetinopathy
researchProduct

Focus group study to identify the central facets of fear of hypoglycaemia in people with Type 2 diabetes mellitus.

2017

Aims To determine key worries about hypoglycaemia among insulin-using adults with Type 2 diabetes using a focus group approach. Methods Thirteen focus groups were conducted in three diabetes outpatient care units and one peer support group was set up, in Germany. A total of 64 insulin-dependent adults with Type 2 diabetes (36.5% women, mean age 65.2 ± 11.0 years) discussed their worries about hypoglycaemia. The qualitative results were assigned into thematic categories using a bottom-up coding procedure. Participants completed the Hypoglycaemia Fear Survey and demographic measures were recorded. The results of the Hypoglycaemia Fear Survey were contrasted with the focus group findings to ev…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedia_common.quotation_subject030209 endocrinology & metabolismType 2 diabetesPeer support03 medical and health sciences0302 clinical medicineEndocrinologyQuality of lifeAmbulatory careDiabetes mellitusGermanyInternal MedicinemedicineHumansHypoglycemic Agents030212 general & internal medicinePsychiatrymedia_commonAgedbusiness.industryType 2 Diabetes MellitusFearAwarenessFocus GroupsMiddle Agedmedicine.diseaseFocus groupHypoglycemiaSelf EfficacyDiabetes Mellitus Type 2Socioeconomic FactorsQuality of LifeFemaleWorrybusinessDiabetic medicine : a journal of the British Diabetic Association
researchProduct

Effects of Glutathione on Red Blood Cell Intracellular Magnesium

1999

Abstract —Recent evidence suggests that the endogenous antioxidant glutathione may play a protective role in cardiovascular disease. To directly investigate the role of glutathione in the regulation of glucose metabolism in hypertension, we studied the acute effects of in vivo infusions of this antioxidant (alone or in combination with insulin) on whole body glucose disposal (WBGD) using euglycemic glucose clamp and the effects on total red blood cell intracellular magnesium (RBC-Mg) in hypertensive (n=20) and normotensive (n=30) subjects. The relationships among WBGD, circulating reduced/oxidized glutathione (GSH/GSSG) levels, and RBC-Mg in both groups were evaluated. The in vitro effects…

AdultMalemedicine.medical_specialtyErythrocytesAntioxidantmedicine.medical_treatmentCarbohydrate metabolismBiologyAntioxidantschemistry.chemical_compoundInsulin resistanceReference ValuesIn vivoInternal medicineInternal MedicinemedicineHumansHypoglycemic AgentsInsulinMagnesiumGlutathione DisulfideInsulinIntracellular MembranesMetabolismGlutathioneMiddle Agedmedicine.diseaseGlutathioneRed blood cellGlucosemedicine.anatomical_structureEndocrinologychemistryHypertensionGlucose Clamp TechniqueFemaleHypertension
researchProduct

Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial

2020

Digital

AdultMalemedicine.medical_specialtyRecombinant Fusion ProteinsGlucagon-Like Peptides030209 endocrinology & metabolismType 2 diabetesPlacebolaw.invention03 medical and health sciences0302 clinical medicineDouble-Blind MethodRandomized controlled triallawInternal medicinemedicineHumansHypoglycemic AgentsCognitive DysfunctionRisk factorAgedbusiness.industryHazard ratioMontreal Cognitive AssessmentMiddle Agedmedicine.diseaseImmunoglobulin Fc FragmentsTreatment OutcomeDiabetes Mellitus Type 2Digit symbol substitution testFemaleDulaglutideNeurology (clinical)business030217 neurology & neurosurgerymedicine.drug
researchProduct

Pioglitazone in addition to metformin improves erythrocyte deformability in patients with Type 2 diabetes mellitus

2010

The aim of the present study was to compare the effect of PIO (pioglitazone) or GLIM (glimepiride) on erythrocyte deformability in T2DM (Type 2 diabetes mellitus). The study covered 23 metformin-treated T2DM patients with an HbA1c (glycated haemoglobin) >6.5%. Patients were randomized to receive either PIO (15 mg, twice a day) or GLIM (1 mg, twice a day) in combination with metformin (850 mg, twice a day) for 6 months. Blood samples were taken for the measurement of fasting glucose, HbA1c, fasting insulin, intact proinsulin, adiponectin and Hct (haematocrit). In addition, the erythrocyte EI (elongation index) was measured using laser diffractoscopy. Both treatments significantly impr…

AdultMalemedicine.medical_specialtyendocrine system diseasesmedicine.medical_treatmentType 2 diabetesInsulin resistanceErythrocyte DeformabilityInternal medicineDiabetes mellitusHumansHypoglycemic AgentsMedicineAgedProinsulinGlycated HemoglobinPioglitazoneAdiponectinbusiness.industryInsulinnutritional and metabolic diseasesGeneral MedicineMiddle Agedmedicine.diseaseMetforminGlimepirideSulfonylurea CompoundsEndocrinologyDiabetes Mellitus Type 2Drug Therapy CombinationFemaleThiazolidinedionesStress MechanicalbusinessPioglitazonemedicine.drugClinical Science
researchProduct

Does metformin induce ovulation in normoandrogenic anovulatory women?

2004

Objective: This study was undertaken to evaluate the efficacy of metformin in women with anovulation who do not have evidence for hyperandrogenism and classic polycystic ovary syndrome. Study design: A randomized trial of metformin (1500 mg daily) and placebo in 24 anovulatory women was undertaken for 3 months. Assessments of changes in hormone levels and insulin sensitivity were carried out. Abnormal ormonal values were defined by levels exceeding the range in normal ovulatory controls. Results: Anovulatory women had normal androgen levels and luteinizing hormone but had higher serum insulin and lower insulin sensitivity compared with controls. Over 3 months, there were 16 ovulatory cycles…

AdultOvulationmedicine.medical_specialtymedia_common.quotation_subjectmedicine.medical_treatmentDrug Administration ScheduleAnovulationInternal medicinemedicineHumansHypoglycemic AgentsInsulinOvulationMenstrual CycleMenstrual cyclemedia_commonbusiness.industryInsulinHyperandrogenismObstetrics and Gynecologymedicine.diseasePolycystic ovaryMetforminMetforminTreatment OutcomeEndocrinologyInfertilityFemaleHyperandrogenismLuteinizing hormonebusinessAnovulationPolycystic Ovary Syndromemedicine.drugAmerican Journal of Obstetrics and Gynecology
researchProduct

Therapeutic inertia in patients with type 2 diabetes treated with non-insulin agents

2021

Abstract Aims To analyze therapeutic inertia in type 2 diabetes (T2D) subjects with suboptimal glycemic control and treated with ≥2 non-insulin antidiabetic agents in a primary care setting. Methods A retrospective study was conducted using electronic medical records from subjects with HbA1c ≥7.0% (≥53 mmol/mol). Therapeutic inertia was defined as the absence of treatment intensification despite suboptimal glycemic control where intensification should have been implemented (HbA1c ≥7.5% [≥58 mmol/mol]). Time to the first intensification with non-insulin antidiabetic agent or insulin and HbA1c values at the time of intensification were evaluated by competing risk analysis. Results 2652 adults…

Adultmedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and Metabolismmedicine.medical_treatmentTreatment intensificationInsulins030209 endocrinology & metabolismType 2 diabetes030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineEndocrinologyInternal medicineDiabetes mellitusInternal MedicinemedicineHumansHypoglycemic AgentsRetrospective StudiesTherapeutic inertiaGlycemicGlycated Hemoglobinbusiness.industryMedical recordInsulinnutritional and metabolic diseasesRetrospective cohort studymedicine.diseaseDiabetes Mellitus Type 2businessJournal of Diabetes and its Complications
researchProduct

Effects of metformin on mitochondrial function of leukocytes from polycystic ovary syndrome patients with insulin resistance.

2015

ObjectiveOxidative stress and mitochondrial dysfunction are implicated in polycystic ovary syndrome (PCOS). The present study assesses the effect of metformin treatment on mitochondrial function in polymorphonuclear cells from PCOS subjects. Additionally, we evaluate endocrine parameters and levels of interleukin 6 (IL6) and tumour necrosis factor alpha (TNFα).Design and methodsOur study population was comprised of 35 women of reproductive age diagnosed with PCOS and treated with metformin for 12 weeks, and their corresponding controls (n=41), adjusted by age and BMI. We evaluated the alteration of endocrinological and anthropometrical parameters and androgen levels. Mitochondrial O2 consum…

Adultmedicine.medical_specialtyendocrine system diseasesNeutrophilsEndocrinology Diabetes and MetabolismMitochondrionBiologymedicine.disease_causechemistry.chemical_compoundYoung AdultEndocrinologyDehydroepiandrosterone sulfateInsulin resistanceInternal medicinemedicineHumansHypoglycemic Agentschemistry.chemical_classificationReactive oxygen speciesInterleukin-6Tumor Necrosis Factor-alphanutritional and metabolic diseasesGeneral MedicineGlutathionemedicine.diseasePolycystic ovaryMetforminMetforminMitochondriaEndocrinologyTreatment OutcomechemistryFemaleInsulin ResistanceOxidative stressmedicine.drugPolycystic Ovary Syndrome
researchProduct